APR 12, 2017 12:00 PM PDT

PAMA: The First Reporting Period is Over. What Does This Legislation Mean for Laboratorie

Speaker
  • Roger D. Klein MD, JD, FCAP

    Principal at Roger D. Klein, MD JD Consulting and Klein & Klein Co., L.P.A. Faculty Fellow at the Arizona State University Sandra Day O'Connor College of Law's Center for Law, Science &
    BIOGRAPHY

Abstract

This presentation describes the new process by which the Centers for Medicare and Medicaid Services (CMS) will establish the prices the Agency pays for clinical diagnostic laboratory tests.  This revolutionary approach was
mandated by Congress in the clinical laboratory provisions contained within Section 216 of the Protecting Access to Medicare Act of 2014.  In his talk Dr. Klein will discuss this legislation, accompanying CMS regulations, and their
potential impacts on the laboratory industry


You May Also Like
APR 12, 2017 12:00 PM PDT

PAMA: The First Reporting Period is Over. What Does This Legislation Mean for Laboratorie



Loading Comments...